KDM6A and neoplasm: Importantly, we demonstrated that KDM6A exerted an antitumour effect by epigenetically activating Rho GDP dissociation inhibitor beta (ARHGDIB) transcription and consequently inhibiting Rac family small GTPase 1 (Rac1), which plays important roles in tumour cell motility, invasiveness, and metastasis.